GPhC Homepage

Sodium Valproate resources and informationRevalidation requirements from October 2022New standards for the initial education and training of pharmacists launched

See our new standards for the initial education and training of pharmacists


We regulate pharmacists, pharmacy technicians and pharmacies in Great Britain.  We work to assure and improve standards of care for people using pharmacy services.


GPhC welcomes new legislation to strengthen pharmacy governance

24 October 2022
New legislative orders will give the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI) powers to set professional standards for Responsible Pharmacists, Superintendent Pharmacists and Chief Pharmacists.

Update on valproate

20 October 2022
Children born to women who take valproate during pregnancy are at significant risk of birth defects and persistent developmental disorders. As such, it is vital that women and girls are dispensed valproate safely. The GPhC is reminding all pharmacy professionals of what they must do to ensure women and girls receive the right information about valproate and the risk of birth defects. 

GPhC publishes guidance on the initial assessment of incoming concerns

20 October 2022
The guidance sets out our revised approach to assessing concerns when they are first received and deciding whether an investigation is required or if other action is more appropriate.

Healthcare regulators publish annual report on whistleblowing disclosures

28 September 2022
The GPhC in conjunction with seven other healthcare professional regulators has published its annual report on whistleblowing disclosures.